繁 / 简 / EN

Global AI Event Kicks Off | SurgicalNext, an Invested Enterprise of GPTX簡坤投資, Makes a Strong Debut with Its "Ultra-Microscopic Robot," Ushering in a New Chapter in Medical Revolution

2025-07-26

On July 26, 2025, the Shanghai World Expo Center buzzed with excitement as the World Artificial Intelligence Conference (WAIC) opened its doors under the theme "Intelligent Era, Shared Global Progress". As a premier global AI event, WAIC drew over 800 domestic and international exhibitors, uniting leading scientists, entrepreneurs, policymakers, and investors to explore cutting-edge topics such as large language models, embodied AI, and AI governance. Chinese Premier Li Qiang's keynote proposal to establish a "Global AI Cooperation Organization" underscored China's rising influence in shaping international AI governance frameworks. Amid this fusion of technology and industry, GPTX簡坤投資 backed SurgicalNext stole the spotlight with groundbreaking innovations, demonstrating China's transition from AI research to real-world impact.

image.png

SurgicalNext: Fully Autonomous Ultra-Microscopic Robot Redefines Surgical Precision

At the Medical Technology Pavilion, SurgicalNext's prototype "Fully Autonomous AI Ultra-Microscopic Robot" captivated audiences. Designed for high-stakes, ultra-precise procedures in neurosurgery, cardiac surgery, and ophthalmology, the robot achieves 10-micron to sub-micron accuracy—10x finer than existing surgical robots and 100x more precise than manual operations. Key differentiators include:

  • Fully Autonomous Operation: Surgeons specify targets; the robot autonomously plans paths, detects tissue deformation, and adjusts strategies in real time. During a live demo, it successfully peeled a quail eggshell without damaging the membrane beneath.
  • Force-Controlled Safety: Millisecond-level force feedback minimizes soft tissue trauma, reducing surgical trauma to 1/10th of current systems.
  • 100% Localized Production: From motors to control systems, the robot relies entirely on domestically manufactured semiconductor components, cutting costs by 70% and enabling affordable access for tier-3/4 city hospitals.

SurgicalNext's "High Value + Standardization" strategy centers on a hardware-subscription-consumables ecosystem. Against the policy backdrop of domestic substitution and tiered healthcare delivery, its intelligent medical devices address manpower shortages in third/fourth-tier hospitals while enabling affordable, high-quality grassroots adoption. GPTX簡坤投資, its lead investor, provided not only capital but also technical expertise, industry networks, and talent development, propelling SurgicalNext from regional player to national leader in medical AI localization.

image.png

In addition, Professor Guo Yike, Academician of the Hong Kong Academy of Engineering Sciences and Provost of the Hong Kong University of Science and Technology, was invited to serve as the presenter for the "AI Person of the Year" award at the 2025 China AI Gala on the evening of July 26, underscoring his academic and societal influence. As the Co-founder of the SurgicalNext, Professor Guo has led his team in deeply integrating "scientific research capabilities" with "real-world applications".

GPTX簡坤投資: The Ecosystem Connector Unlocking AI Ecosystem Synergy

WAIC 2025 transcended a mere technology showcase, embodying a "Tech-Capital-Ecosystem" collaborative evolution. SurgicalNext's breakthroughs validate GPTX簡坤投資's "Venture Capital + Ecosystem Enablement" model. In the AI era, isolated technological advances are insufficient; true transformation requires harmonizing innovation, industry networks, and capital. GPTX簡坤投資 positions itself as an "ecosystem connector", aligning stakeholders to ensure technology serves societal well-being.

As SurgicalNext's micro-robot delicately peels eggshells, China's AI ecosystem is driving global industry transformation through "hard tech + soft governance". The story of GPTX簡坤投資 and its invested enterprises perfectly embodies the balance between technological idealism and commercial pragmatism—only through ecosystem co-construction can we achieve shared intelligence and mutual prosperity.

About Us

GPTX Investment Management Limited (「GPTX簡坤投資」) was incorporated in Hong Kong on November 24, 2022, with registered and fully paid-up capital of HK$100 million. It has obtained uplifted licenses for Type 1 (dealing in securities), Type 4 (advising on securities), and Type 9 (asset management) from the Securities and Futures Commission of Hong Kong (「SFC」) to engage in corresponding regulated activities (CE No.: BTV456).

Guided by the unwavering mission to create sustainable value for investors, GPTX簡坤投資 is committed to becoming a global leading digital investment pioneer. Through a diversified product matrix, it delivers tailored investment opportunities that meet clients’ evolving needs. Its products comprise two major categories: public funds and private funds. Geographically, the offerings cover Cayman Islands, Hong Kong, and the British Virgin Islands. Leveraging a range of strategies, including fixed income, fixed income plus, multi-assets, digital assets, and private equity, it provides risk-balanced, forward-looking solutions that balance short-term stability with long-term strategic growth.